Skip to content
EA

If it needs evidence from several people and someone to sign it off, hand it to EA.

Browse the full library

Access to Medicine Index · AMR Benchmark

Your access to medicine record, in your own evidence.

The Access to Medicine Foundation chooses which companies its Index and its antimicrobial resistance (AMR) Benchmark assess. If yours is one, EA drafts the Foundation’s survey from last cycle’s submission, your access plans and registration records, asks R&D, market access and manufacturing for what only they hold, and brings it to your Head of Sustainability to approve.

Try EA free. No card needed.

Organisations that run work on EA

The work

Two years apart, and never quite the same survey.

  • The methodology moves between cycles

    The 2026 Index cut its indicators from 32 to 29, widened the diseases it covers and redefined inclusive business models, so last cycle’s answers no longer line up one for one.

  • Every function holds a piece

    Access plans sit with the portfolio team, registrations and prices with market access, discharge audits with manufacturing and licences with legal, across 113 countries.

  • The people who answered last time have moved

    Two years is long enough for the colleague who wrote last cycle’s patient reach answer to have changed roles, taking the reasoning with them.

The Foundation reads your public record either way. The survey is where your own evidence sits beside it, each answer with the team that stands behind it.

The 2026 methodology

Over half the score is evidence held market by market.

The Foundation weights the 2026 Index across three technical areas, covering 113 low- and middle-income countries and 84 diseases, conditions and pathogens. The heaviest draws on the evidence spread furthest across your company, and that is where EA’s asks go.

  • 55 per centProduct Delivery, answered from the registrations, prices, licences and supply that market access, legal and manufacturing hold in each country
  • 30 per centResearch and Development, answered from the pipeline and the access plan your portfolio team holds for each candidate
  • 15 per centGovernance of Access, answered from the board oversight, incentives, compliance record and patient reach measurement your access and compliance teams keep

Access to Medicine Foundation, 2026 Index methodology.

What EA does

From last cycle’s answers to this cycle’s indicators.

One company’s Index survey in EA, from the new methodology to the submission your team makes. An AMR Benchmark survey runs the same way across its 16 indicators, with manufacturing’s discharge audits among the asks.

01 / 04

  1. EA

    Reads the 2026 methodology beside your last submission and report card, carries each answer to the indicator that now asks it, and marks what changed: answers given to the three retired indicators, the patient reach reporting the methodology now asks more of, and the diseases added to the scope. Knowledge Library 

    Your team

    The Global Health Lead decides what carries over and assigns each technical area to its owner.

  2. EA

    Drafts each answer from your access strategy, portfolio committee minutes, pricing policies and licence agreements, with the source beside it, and puts your own record beside each figure the Foundation drew from public sources. Knowledge Library 

    Your team

    Your team confirms or corrects the Foundation’s figures, and decides which programmes meet its definitions.

  3. EA

    Sends one ask per owner, such as registrations by country to the Head of Market Access and discharge audits to the Head of Environment, Health and Safety, follows up, and files each reply against its indicator. EA Agent 

    Your team

    The Global Health Lead sees what is still due across all three technical areas.

  4. EA

    Brings the survey together with the source and reviewer beside each answer, and exports it in the Foundation’s order. Approvals 

    Your team

    The Head of Sustainability approves; your team submits, and answers the Foundation’s verification questions.

Illustrative data

See a late-stage candidate’s access plan become the answer the Foundation reads.

Book a demo

Next cycle

The next survey starts where this one was approved.

  • A new methodology

    When the Foundation publishes the next methodology, EA sets this cycle’s answers against it, so your team reads what changed rather than the whole survey.

  • Your report card’s findings

    The actions the report card points to are kept beside the answers they concern, so the next cycle can show what was done.

  • The same evidence for other askers

    When investors or a rating agency ask about access to medicine, EA drafts the answer from this cycle’s survey, each figure with its source.

Illustrative data
Approval record · Research and Development access plansLocked
Answer
Access plans for late-stage candidates
Source
Portfolio committee minutes, March 2026
Approved by
Head of Sustainability
Used in
Next cycle’s starting draft

EA’s own security

The pipeline stays with the people you choose.

The survey draws on candidates, licence terms and prices by country that you don’t publish.

  • Hosted your way

    EA’s cloud in a region you choose, hybrid options or on-premises. Data never used to train the models EA runs on.

  • Access

    Single sign-on, which you can enforce, and an access list for each workspace.

  • Support access

    EA staff see your data only in a time-limited window you open.

  • Testing

    An independent firm runs a penetration test on EA every year.

  • Security contact

    EA’s security team is at security@eaglobal.ai.

See how the portfolio team answers its own indicators while prices by country stay with market access.

Book a demo

FAQ

Questions from companies in the Foundation’s scope.

The Foundation decides who is in scope: 20 large research-based companies for the Index, and for the 2026 AMR Benchmark 25 companies, from large research-based firms to generic manufacturers and smaller companies. A company it names is assessed from public data even without a survey response, so the survey is where your own records are added. EA is for the companies preparing that response.

The Foundation does. It cross-checks each answer against public sources, has key sections reviewed by independent experts, including its Expert Review Committee, and publishes the Index ranking with a report card for each company; the AMR Benchmark scores each company without ranking them. Your team submits the survey and answers the Foundation’s clarification questions.

Whether a programme meets the Foundation’s definition, such as an inclusive business model, is your team’s call. EA drafts each answer from the record behind it, and if the draft describes a pricing scheme with no patient reach data on file, it marks the answer “Needs evidence” and asks the Head of Market Access.

Only the colleagues you add. The Head of Legal can answer the licensing indicators without opening the portfolio committee minutes, and the Head of Environment, Health and Safety sees only the manufacturing indicators.

With last cycle’s submission, the Foundation’s clarification questions, your report card and the current methodology, as they are. Our Customer Success team helps with exports from other platforms. Plans differ by the number of autofills, the workspaces you need and the size of your knowledge library; see the pricing page.

Your next access survey, without rebuilding two years of evidence.

One indicator, from last cycle to your Head of Sustainability.

Related solutions

By industry